Clinical trial
Optimizing Electroconvulsive Therapy for Depression
NCT00045916 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00045916 |
|---|---|
| Title | Optimizing Electroconvulsive Therapy for Depression |
| Official title | Optimization of Electroconvulsive Therapy |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Depressive Disorder, Bipolar Disorder |
| Intervention type | Drug, Procedure |
| Interventions | High dosage electroconvulsive therapy, Nortriptyline, Venlafaxine, Lithium, Low dosage electroconvulsive therapy |
| Enrollment | 340 |
| Start date | Feb 1, 2001 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 17, 2002 |
| Last update posted | Aug 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: